Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.87 USD | +1.21% | -3.32% | +17.88% |
May. 28 | Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors, Effective June 1, 2024 | CI |
May. 08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |